Medibuilder Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Medibuilder Co., Ltd. - overview
Established
2022
Location
Seoul, -, South Korea
Primary Industry
Business Support Services
About
Based in Seoul, South Korea, and founded in 2022,Medibuilder Co. , Ltd. operates as a medical accelerator company that conducts business under the SMC model which establishes business management for various partner hospitals. In February 2023, MEDIBUILDER raised KRW 9 billion in series A funding from returning investor BASS Investment, with participation from new investor LB Investment.
The company provides strategies for digitalization, division of labor, specialization of the hospital, and internalizes performance marketing capabilities to increase hospital sales. The company offers various support services to healthcare companies by partnering with them and offering various management services and contributing to their growth. The company plans to use the February 2023 funding to strengthen its education, personnel, development, and overseas marketing capabilities.
Current Investors
Bass Ventures, LB Investment, KDB Bank
Primary Industry
Business Support Services
Sub Industries
Business Support Services, Healthcare, Healthcare IT
Website
https://medibuilder.career.greetinghr.com/
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.